FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
FDA General

Replacement Named for Retiring Rachel Sherman

FDA announces that former Flatiron Health chief medical officer Amy Abernethy will replace retiring Rachel Sherman as the agencys principal deputy com...

Human Drugs

Torrent Pharma Expands Losartan Recall

Torrent Pharmaceuticals expands an earlier recall from two lots of hypertension drug losartan potassium tablets USP to a total of 10 lots due to the d...

Human Drugs

Nabriva NDA for Urinary Tract Infections Antibiotic

FDA accepts a Nabriva Therapeutics NDA and granted a priority review for Contepo (fosfomycin for injection) to treat complicated urinary tract infecti...

Medical Devices

Endologix Restricts Nellix Stent Graft

Endologix says it is discontinuing unrestricted sales of its Nellix stent graft for treating abdominal aortic aneurysms and limiting its use to pre-sc...

Human Drugs

Verrica Pharma NDA Planned for Skin Disease Drug

Verrica Pharmaceuticals says it is planning an NDA submission in the second half of the year for VP-102 for treating molluscum contagiosum, a highly c...

Medical Devices

Akonni Biosystems 510(k) for TruDiagnosis System

Akonni Biosystems files a 510(k) to market the TruDiagnosis system, its proprietary microarray-based technology.

Human Drugs

FDA Co-sponsors PBPK Drug Modeling Conference

FDA and the American Society for Clinical Pharmacology and Therapeutics co-sponsor a 3/13 conference on PBPK Modeling for the Development and Approval...

Human Drugs

StemCyte Study of Cell Therapy Drug Approved

FDA approves a StemCyte IND to conduct a Phase 2 trial of its Allogeneic Human Leukocyte Antigen-Matched Umbilical Cord Blood Mononuclear Stem Cells f...

Medical Devices

Tivic Health Gains Clearance for Sinus Pain Reliever

FDA clears a Tivic Health Systems 510(k) for the ClearUP Sinus Pain Relief, a bioelectronic treatment for sinus pain due to allergic rhinitis.

Human Drugs

Shutdown Causes Endo Litigation Delay

FDA asks the DC federal court to continue a stay on Endos drug bulk compounding suit against it until the government shutdown ends.